Having trouble accessing articles? Reset your cache.

Biodel completes direct public offering

Biodel Inc. (NASDAQ:BIOD), Danbury, Conn.
Business: Endocrine, Drug delivery
Date completed:

Read the full 116 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE